Self-monitoring of blood glucose (SMBG) is the most accessible way to assess glycemic patterns, and interpretation of these patterns can provide reasons for poor glycemic control and suggest management strategies. Furthermore, diabetes management based on blood glucose (BG) patterns is associated with improved patient outcomes. The aim of this review is therefore to evaluate the impact of pattern management in clinical practice.
Methods:
We included a review of available literature, a discussion of obstacles to implementation of SMBG and pattern management, and suggestions on how clinicians and patients might work together to optimize this management feature.
Results:
The literature review revealed eight publications specifically describing structured approaches to SMBG and pattern management. Specific information on how SMBG might be structured to detect BG patterns, however, remains limited. Barriers to pattern management include not just practical reasons, but emotional and psychological reasons as well.
Conclusions:
Patterns are not always easy to detect or interpret, but on-meter and web-based tools can support both patients and clinicians. Ultimately, successful pattern management requires education and mutual commitment from the clinician and patient—ongoing collaboration is needed to obtain, review, and interpret SMBG values and to make changes based on the patterns.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352 (9131): 837–53.
2.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329 (14): 977–86.
3.
Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes. 1997; 46 (2): 271–86.
4.
Action to Control Cardiovascular Risk in Diabetes Study Group, GersteinHCMillerMEByingtonRPGoffDCJrBiggerJTBuseJBCushmanWCGenuthSIsmail-BeigiFGrimmRHJrProbstfieldJLSimons-MortonDGFriedewaldWT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358 (24): 2545–59.
CryerPE. The barrier of hypoglycemia in diabetes. Diabetes. 2008; 57 (12): 3169–76.
7.
McCrimmonRJFrierBM. Hypoglycaemia, the most feared complication of insulin therapy. Diabete Metab. 1994; 20 (6): 503–12.
8.
ThompsonCJCummingsJFChalmersJGouldCNewtonRW. How have patients reacted to the implications of the DCCT?Diabetes Care. 1996; 19 (8): 876–9.
9.
PickupJCKiddJBurmistonSYemaneN. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: Importance of blood glucose variability. Diabetes Metab Res Rev. 2006; 22 (3): 232–7.
10.
AlemzadehRLoppnowCPartonEKirbyM. Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus. Diabetes Technol Ther. 2003; 5 (2): 167–73.
11.
ServiceFJO'BrienPC. The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial. Diabetologia. 2001; 44 (10): 1215–20.
12.
BergenstalRMGavinJR3rd; Global Consensus Conference on Glucose Monitoring Panel. The role of self-monitoring of blood glucose in the care of people with diabetes: Report of a global consensus conference. Am J Med. 2005; 118 (suppl 9A): 1S–6S.
13.
DaileyG. Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements. Mayo Clin Proc. 2007; 82 (2): 229–36.
14.
St JohnADavisWAPriceCPDavisTM. The value of self-monitoring of blood glucose: A review of recent evidence. J Diabetes Complications. 2010; 24 (2): 129–41.
15.
DaviesMStormsFShutlerSBianchi-BiscayMGomisR; ATLANTUS Study Group. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: Comparison of two treatment algorithms using insulin glargine. Diabetes Care. 2005; 28 (6): 1282–8.
16.
PolonskyWHFisherLSchikmanCHHinnenDAParkinCGJelsovskyZPetersenBSchweitzerMWagnerRS. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: Results from the Structured Testing Program study. Diabetes Care. 2011; 34 (2): 262–7.
17.
PearsonJBergenstalR. Fine-tuning control: Pattern management versus supplementation. View 1: Pattern management: An essential component of effective insulin management. Diabetes Spectr. 2001; 14: 75–8.
18.
DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: Dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ. 2002; 325 (7367): 746.
19.
SämannAMühlhauserIBenderRHunger-DatheWKloosCMüllerUA. Flexible intensive insulin therapy in adults with type 1 diabetes and high risk for severe hypoglycemia and diabetic ketoacidosis. Diabetes Care. 2006; 29 (10): 2196–9.
20.
SämannAMühlhauserIBenderRKloosChMüllerUA. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: A prospective implementation study. Diabetologia. 2005; 48 (10): 1965–70.
21.
PieberTRBrunnerGASchnedlWJSchattenbergSKaufmannPKrejsGJ. Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care. 1995; 18 (5): 625–30.
22.
CholeauCAlbisserAMBar-HenABihanHCampinosCGherbiZJomaaRAichMCohenRReachG. A novel method for assessing insulin dose adjustments by patients with diabetes. J Diabetes Sci Technol. 2007; 1 (1): 3–7.
23.
ReachG. Can technology improve adherence to long-term therapies?J Diabetes Sci Technol. 2009; 3 (3): 492–9.
24.
ReachG. Patient non-adherence and healthcare-provider inertia are clinical myopia. Diabetes Metab. 2008; 34 (4 Pt 1): 382–5.
25.
ReachG. A psychophysical account of patient non-adherence to medical prescriptions. The case of insulin dose adjustment. Diabetes Metab. 2013; 39 (1): 50–5.
26.
PolonskyWHFisherLSchikmanCHHinnenDAParkinCGJelsovskyZAxel-SchweitzerMPetersenBWagnerRS. A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: Results from the STeP study. Diabetes Technol Ther. 2011; 13 (8): 797–802.
27.
PolonskyWHJelsovskyZPanzeraSParkinCGWagnerRS. Primary care physicians identify and act upon glycemic abnormalities found in structured, episodic blood glucose monitoring data from non-insulin-treated type 2 diabetes. Diabetes Technol Ther. 2009; 11 (5): 283–91.
28.
LalicNTankovaTNourredineMParkinCSchweppeUAmann-ZalanI. Value and utility of structured self-monitoring of blood glucose in real world clinical practice: Findings from a multinational observational study. Diabetes Technol Ther. 2012; 14 (4): 338–43.
29.
RodbardHWSchnellOUngerJReesCAmstutzLParkinCGJelsovskyZWegmannNAxel-SchweitzerMWagnerRS. Use of an automated decision support tool optimizes clinicians' ability to interpret and appropriately respond to structured self-monitoring of blood glucose data. Diabetes Care. 2012; 35 (4): 693–8.
30.
CoxDJGonder-FrederickLRitterbandLClarkeWKovatchevBP. Prediction of severe hypoglycemia. Diabetes Care. 2007; 30 (6): 1370–3.
31.
KempfKKruseJMartinS. ROSSO-in-praxi: A self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus. Diabetes Technol Ther. 2010; 12 (7): 547–53.
32.
HansenMVPedersen-BjergaardUHellerSRWallaceTMRasmussenAKJørgensenHVPrammingSThorsteinssonB. Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res Clin Pract. 2009; 85 (2): 183–8.
33.
MazzeRSShamoonHPasmantierRLucidoDMurphyJHartmannKKuykendallVLopatinW. Reliability of blood glucose monitoring by patients with diabetes mellitus. Am J Med. 1984; 77 (2): 211–7.
34.
ReachG. Two character traits associated with adherence to long term therapies. Diabetes Res Clin Pract. 2012; 98 (1): 19–25.
35.
AinslieG. Précis of breakdown of will. Behav Brain Sci. 2005; 28 (5): 635–73.
36.
ReachG. Obstacles to patient education in chronic diseases: A trans-theoretical analysis. Patient Educ Couns. 2009; 77 (2): 192–6.
37.
KahnemanDTverskyA. Prospect theory: An analysis of decision under risk. Econometrica. 1979; 47 (2): 263–92.
38.
TverskyAKahnemanD. Judgment under uncertainty: Heuristics and biases. Science. 1974; 185 (4157): 1124–31.
39.
BaumeisterRFBratslavskyEFinkenauerCVohsKD. Bad is stronger than good. Rev Gen Psychol. 2001; 5 (4): 323–70.
40.
TeftG. Lipohypertrophy: Patient awareness and implications for practice. J Diabetes Nurs. 2002; 6 (1): 20–3.
41.
RodbardHWSchnellOUngerJReesCAmstutzLParkinCGJelsovskyZWegmannNAxel-SchweitzerMWagnerRS. Use of an automated decision support tool optimizes clinicians' ability to interpret and appropriately respond to structured self-monitoring of blood glucose data. Diabetes Care. 2012; 35 (4): 693–8.
WelshJBMyersSJUhrinakANKaufmanFRLeeSW. User acceptability and perceived benefits of new reports in CareLink Pro 3.0 Therapy Management Software for Diabetes. J Diabetes Sci Technol. 2012; 6 (2): 481–2.
44.
International Diabetes Federation. Guideline. Self-monitoring of blood glucose in non-insulin treated type 2 diabetes. 2009. http://www.idf.org/webdata/docs/SMBG_EN2.pdf. Accessed April 2012.
45.
KlonoffDCBergenstalRBlondeLBorenSAChurchTSGaffaneyJJovanovicLKendallDMKollmanCKovatchevBPLeippertCOwensDRPolonskyWHReachGRenardERiddellMCRubinRRSchnellOSiminieroLMVigerskyRAWilsonDMWollitzerAO. Consensus report of the coalition for clinical research-self-monitoring of blood glucose. J Diabetes Sci Technol. 2008; 2 (6): 1030–53.
46.
ParkinCGDavidsonJA. Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes. J Diabetes Sci Technol. 2009; 3 (3): 500–8.
47.
PeelEDouglasMLawtonJ. Self monitoring of blood glucose in type 2 diabetes: Longitudinal qualitative study of patients' perspectives. BMJ. 2007; 335 (7618): 493.
